- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00150410
Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose
October 28, 2008 updated by: Pfizer
A One-Year, Open, Randomized, Parallel, Three-Arm Study Comparing Exubera® (Insulin Dry Powder Pulmonary Inhaler) vs. Avandia® (Rosiglitazone Maleate) as Add-On Therapy vs. Exubera® Substitution of Sulfonylurea in Patients With Type 2 Diabetes, Poorly Controlled on Combination Sulfonylurea and Metformin Treatment
- Whether a combination of three therapies - metformin and a sulfonylurea plus Exubera, an investigational drug, controls your diabetes at least as much as a triple combination therapy of metformin and a sulfonylurea plus Avandia, a Food and Drug Administration (FDA) approved drug.
- Whether a combination of two therapies - metformin plus Exubera controls your diabetes at least as much as a as a triple combination therapy of metformin and a sulfonylurea plus Avandia.
Study Overview
Study Type
Interventional
Enrollment (Actual)
626
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New South Wales
-
Camperdown, New South Wales, Australia, 2050
- Pfizer Investigational Site
-
Wollongong, New South Wales, Australia, 2500
- Pfizer Investigational Site
-
-
Queensland
-
Herston, Queensland, Australia, 4029
- Pfizer Investigational Site
-
Woolloongabba, Queensland, Australia, 4102
- Pfizer Investigational Site
-
-
South Australia
-
Keswick, South Australia, Australia, 5035
- Pfizer Investigational Site
-
-
Victoria
-
Box Hill, Victoria, Australia, 3128
- Pfizer Investigational Site
-
Caulfield, Victoria, Australia, 3162
- Pfizer Investigational Site
-
-
-
-
RS
-
Porto Alegre, RS, Brazil, 90035-170
- Pfizer Investigational Site
-
-
SP
-
Sao Paulo, SP, Brazil, 01244-030
- Pfizer Investigational Site
-
Sao Paulo, SP, Brazil, 04231-030
- Pfizer Investigational Site
-
-
-
-
-
St. John's, Canada, A1E 2E2
- Pfizer Investigational Site
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3E 3P4
- Pfizer Investigational Site
-
-
Ontario
-
London, Ontario, Canada, N6A 4V2
- Pfizer Investigational Site
-
Mississauga, Ontario, Canada, L5M2V8
- Pfizer Investigational Site
-
Oakville, Ontario, Canada, L6H 3P1
- Pfizer Investigational Site
-
Thornhill, Ontario, Canada, L4J 1V8
- Pfizer Investigational Site
-
Toronto, Ontario, Canada, M4N-3M5
- Pfizer Investigational Site
-
Toronto, Ontario, Canada, M4R 2G4
- Pfizer Investigational Site
-
-
Quebec
-
Laval, Quebec, Canada, H7T 2P5
- Pfizer Investigational Site
-
Montreal, Quebec, Canada, H1T 2M4
- Pfizer Investigational Site
-
St Jerome, Quebec, Canada, J7Z 5T3
- Pfizer Investigational Site
-
Vaudreuil, Quebec, Canada, J7V 8P9
- Pfizer Investigational Site
-
-
-
-
-
Mexico Df, Mexico, CP 14000
- Pfizer Investigational Site
-
-
DF
-
Mexico, DF, Mexico, 02990
- Pfizer Investigational Site
-
Mexico, DF, Mexico, 03100
- Pfizer Investigational Site
-
-
Jalisco
-
Guadalajara, Jalisco, Mexico, 44340
- Pfizer Investigational Site
-
Guadalajara, Jalisco, Mexico, 44349
- Pfizer Investigational Site
-
Guadalajara, Jalisco, Mexico, 44660
- Pfizer Investigational Site
-
-
Jalisco/Mexico
-
Guadalajara, Jalisco/Mexico, Mexico, 44347
- Pfizer Investigational Site
-
-
Nuevo Leon
-
Monterrey, Nuevo Leon, Mexico, 64060
- Pfizer Investigational Site
-
-
Veracruz
-
Jalapa, Veracruz, Mexico, 91020
- Pfizer Investigational Site
-
-
-
-
Arizona
-
Mesa, Arizona, United States, 85205
- Pfizer Investigational Site
-
Phoenix, Arizona, United States, 85012
- Pfizer Investigational Site
-
Tucson, Arizona, United States, 85715
- Pfizer Investigational Site
-
-
Arkansas
-
Searcy, Arkansas, United States, 72143
- Pfizer Investigational Site
-
-
California
-
Alhambra, California, United States, 91801
- Pfizer Investigational Site
-
Concord, California, United States, 94520
- Pfizer Investigational Site
-
Huntington Beach, California, United States, 92648
- Pfizer Investigational Site
-
Huntington Beach, California, United States, 92647
- Pfizer Investigational Site
-
La Jolla, California, United States, 92037
- Pfizer Investigational Site
-
Long Beach, California, United States, 90806
- Pfizer Investigational Site
-
Long Beach, California, United States, 90805
- Pfizer Investigational Site
-
Los Angeles, California, United States, 90048
- Pfizer Investigational Site
-
Riverside, California, United States, 92506
- Pfizer Investigational Site
-
Santa Barbara, California, United States, 93105
- Pfizer Investigational Site
-
Tustin, California, United States, 92780
- Pfizer Investigational Site
-
Westminster, California, United States, 92683
- Pfizer Investigational Site
-
-
Colorado
-
Denver, Colorado, United States, 80209
- Pfizer Investigational Site
-
Wheat Ridge, Colorado, United States, 80033
- Pfizer Investigational Site
-
-
Connecticut
-
Waterbury, Connecticut, United States, 06708
- Pfizer Investigational Site
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
- Pfizer Investigational Site
-
Washington, District of Columbia, United States, 20307
- Pfizer Investigational Site
-
-
Florida
-
Hollywood, Florida, United States, 33021
- Pfizer Investigational Site
-
West Palm Beach, Florida, United States, 33401
- Pfizer Investigational Site
-
Winter Park, Florida, United States, 32789
- Pfizer Investigational Site
-
-
Georgia
-
Atlanta, Georgia, United States, 30309
- Pfizer Investigational Site
-
Augusta, Georgia, United States, 30909
- Pfizer Investigational Site
-
Savannah, Georgia, United States, 31405
- Pfizer Investigational Site
-
Savannah, Georgia, United States, 31419
- Pfizer Investigational Site
-
-
Hawaii
-
Ewa Beach, Hawaii, United States, 96706
- Pfizer Investigational Site
-
Honolulu, Hawaii, United States, 96813
- Pfizer Investigational Site
-
-
Idaho
-
Idaho Falls, Idaho, United States, 83404-6370
- Pfizer Investigational Site
-
Idaho Falls, Idaho, United States, 83404-7542
- Pfizer Investigational Site
-
Idaho Falls,, Idaho, United States, 83404-7542
- Pfizer Investigational Site
-
-
Illinois
-
Chicago Heights, Illinois, United States, 60411
- Pfizer Investigational Site
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Pfizer Investigational Site
-
-
Iowa
-
Des Moines, Iowa, United States, 50314
- Pfizer Investigational Site
-
-
Kansas
-
Wichita, Kansas, United States, 67203
- Pfizer Investigational Site
-
-
Kentucky
-
Lexington, Kentucky, United States, 40503
- Pfizer Investigational Site
-
Louisville, Kentucky, United States, 40213
- Pfizer Investigational Site
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70808
- Pfizer Investigational Site
-
New Orleans, Louisiana, United States, 70112
- Pfizer Investigational Site
-
-
Maryland
-
Baltimore, Maryland, United States, 21204
- Pfizer Investigational Site
-
-
Massachusetts
-
Springfield, Massachusetts, United States, 01103
- Pfizer Investigational Site
-
Springfield, Massachusetts, United States, 01199
- Pfizer Investigational Site
-
Waltham, Massachusetts, United States, 02453
- Pfizer Investigational Site
-
-
Minnesota
-
West St. Paul, Minnesota, United States, 55118
- Pfizer Investigational Site
-
-
Missouri
-
North Kansas City, Missouri, United States, 64116
- Pfizer Investigational Site
-
St. Louis, Missouri, United States, 63141
- Pfizer Investigational Site
-
-
Montana
-
Butte, Montana, United States, 59701
- Pfizer Investigational Site
-
-
Nebraska
-
Lincoln, Nebraska, United States, 68521
- Pfizer Investigational Site
-
-
New Jersey
-
New Brunswick, New Jersey, United States, 08903
- Pfizer Investigational Site
-
New Brunswick, New Jersey, United States, 08901
- Pfizer Investigational Site
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87106
- Pfizer Investigational Site
-
-
New York
-
Albany, New York, United States, 12208
- Pfizer Investigational Site
-
Flushing, New York, United States, 11365
- Pfizer Investigational Site
-
Mineola, New York, United States, 11501
- Pfizer Investigational Site
-
New Hyde Park, New York, United States, 11042
- Pfizer Investigational Site
-
Rochester, New York, United States, 14642
- Pfizer Investigational Site
-
-
North Carolina
-
Raleigh, North Carolina, United States, 27609
- Pfizer Investigational Site
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- Pfizer Investigational Site
-
Cleveland, Ohio, United States, 44195
- Pfizer Investigational Site
-
Lakewood, Ohio, United States, 44107
- Pfizer Investigational Site
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73104
- Pfizer Investigational Site
-
-
Oregon
-
Portland, Oregon, United States, 97210
- Pfizer Investigational Site
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15235
- Pfizer Investigational Site
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Pfizer Investigational Site
-
Charleston, South Carolina, United States, 29401-5799
- Pfizer Investigational Site
-
Duncan, South Carolina, United States, 29334
- Pfizer Investigational Site
-
Spartanburg, South Carolina, United States, 29303
- Pfizer Investigational Site
-
Spartanburg, South Carolina, United States, 29307
- Pfizer Investigational Site
-
Sumter, South Carolina, United States, 29150
- Pfizer Investigational Site
-
-
Tennessee
-
Kingsport, Tennessee, United States, 37660
- Pfizer Investigational Site
-
Knoxville, Tennessee, United States, 37909
- Pfizer Investigational Site
-
Memphis, Tennessee, United States, 38119
- Pfizer Investigational Site
-
Nashville, Tennessee, United States, 37232
- Pfizer Investigational Site
-
-
Texas
-
Corpus Christi, Texas, United States, 78411
- Pfizer Investigational Site
-
Dallas, Texas, United States, 75230
- Pfizer Investigational Site
-
Dallas, Texas, United States, 75246
- Pfizer Investigational Site
-
El Paso, Texas, United States, 79935
- Pfizer Investigational Site
-
El Paso, Texas, United States, 79925
- Pfizer Investigational Site
-
San Antonio, Texas, United States, 78229
- Pfizer Investigational Site
-
San Antonio, Texas, United States, 78237
- Pfizer Investigational Site
-
-
Utah
-
Ogden, Utah, United States, 84403
- Pfizer Investigational Site
-
-
Virginia
-
Fredericksburg, Virginia, United States, 22401
- Pfizer Investigational Site
-
Richmond, Virginia, United States, 23294
- Pfizer Investigational Site
-
Richmond, Virginia, United States, 23221
- Pfizer Investigational Site
-
-
Washington
-
Renton, Washington, United States, 98055
- Pfizer Investigational Site
-
Tukwila, Washington, United States, 98188
- Pfizer Investigational Site
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53209
- Pfizer Investigational Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Type 2 diabetes
- Currently treated and on a stable doses of drugs for the preceding two (2) months
Exclusion Criteria:
- Type 1 Diabetes
- Smoking
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Glycosylated hemoglobin
|
Secondary Outcome Measures
Outcome Measure |
---|
Change from baseline in fasting plasma glucose. Other secondary efficacy
|
endpoints include, body weight, patient reported outcomes, incidence and severity
|
of hypoglycemic episodes, cough questionnaire, and discontinuation rate due to
|
insufficient clinical response.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2003
Study Completion (Actual)
June 1, 2007
Study Registration Dates
First Submitted
September 6, 2005
First Submitted That Met QC Criteria
September 6, 2005
First Posted (Estimate)
September 8, 2005
Study Record Updates
Last Update Posted (Estimate)
October 31, 2008
Last Update Submitted That Met QC Criteria
October 28, 2008
Last Verified
October 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- A2171017
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Medical College of WisconsinMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical College of WisconsinMedical University of South Carolina; National Institute of Diabetes and Digestive...Active, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Joslin Diabetes CenterCambridge Medical Technologies, LLCCompletedType 2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
Clinical Trials on Inhaled insulin
-
PfizerTerminatedDiabetes Mellitus, Type 1United States, Canada, Brazil, Mexico, Argentina
-
PfizerSanofiCompletedDiabetes Mellitus, Type 1United States
-
PfizerTerminatedDiabetes MellitusCanada, United States, Brazil, Puerto Rico
-
PfizerTerminatedDiabetes Mellitus | Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Brazil, Costa Rica, Germany
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Austria
-
PfizerCompletedDiabetes Mellitus, Type 1United States, Canada
-
PfizerSanofiCompletedDiabetes MellitusUnited States, Canada, Spain, Italy, United Kingdom, Germany, France
-
PfizerSanofiCompletedDiabetes Mellitus, Type 2United States
-
PfizerCompletedDiabetes Mellitus | AsthmaUnited States, Canada, Brazil, Costa Rica, Germany
-
PfizerCompletedDiabetes Mellitus, Type 2United States, Puerto Rico